Collaborating With Community Providers in Treating Patients With Complex R/R FL

EP: 1.Overview of R/R FL: Focus on the 3rd-Line Setting and Beyond START

EP: 2.Managing 3rd-Line R/R FL: Recognizing Progression, Performing Rebiopsies, and Rechecking for CD20 Positivity

EP: 3.Aligning Treatment Goals in R/R FL: Physician vs Patient Perspectives

EP: 4.Clinical Scenario: A 73-Year-Old Patient With R/R FL Requires Treatment in the Third-Line Setting

EP: 5.Expert Perspectives: Tazemetostat in R/R FL

EP: 6.Choosing Between Tazemetostat and Zanubrutinib+Obinutuzumab: Key Factors & Patient Conversations

EP: 7.Assessing CAR T and Bispecifics for R/R FL: Identifying the Right Candidates & Factoring in CD20 and CD19 Negativity or Positivity

EP: 8.Navigating Treatment Choices in R/R FL: Patient Values and Shared Decision-Making

EP: 9.Managing R/R FL: Evolving Sequencing Strategies

EP: 10.Key Strategies and Perspectives: How Novel 2nd-Line Therapy Options May Impact 3rd-Line Treatment Landscape in R/R FL and Bridging Strategies to CAR T

Now Viewing

EP: 11.Collaborating With Community Providers in Treating Patients With Complex R/R FL

EP: 12.Looking Ahead in R/R FL: Unmet Needs and What’s Next

Summary for Physicians:

Collaborating with community physicians and providers is essential in treating patients with complex cancer, particularly those requiring advanced therapies such as CAR T, bispecific antibodies, or targeted treatments. Effective collaboration ensures continuity of care and allows for better patient outcomes. Here are some strategies to facilitate this collaboration:

1. Clear Communication: Establish open and regular communication with community providers, ensuring they are informed about the patient’s diagnosis, treatment plan, and progress. This includes discussing treatment options, adverse effects, and any adjustments to the regimen.
2. Shared Care Plans: Develop a shared care plan that outlines the roles and responsibilities of both the specialized treatment center and the community providers. This can include treatment timelines, monitoring requirements, and follow-up schedules to ensure both parties are aligned.
3. Education and Support: Provide ongoing education to community physicians about the latest treatment options, adverse effect management, and how to handle complications. This ensures that community providers are equipped to treat patients appropriately at all stages of therapy.
4. Referral Networks: Maintain strong referral relationships for situations that require specialized interventions, such as CAR T therapy administration or managing adverse effects such as cytokine release syndrome. Establishing these networks ensures that patients receive the highest level of care when necessary.
5. Regular Monitoring: Encourage community providers to monitor patients regularly for potential adverse effects and disease progression, while also ensuring patients have access to specialized care when needed for more intensive treatments or complications.
6. Patient Advocacy: Keep patients and their families involved in the care process by explaining the treatment plan and ensuring they understand the roles of the community providers and specialists. This collaborative approach enhances patient satisfaction and engagement in their treatment journey.

Overall, collaboration between community and specialized providers is critical for treating patients with complex cancer effectively, ensuring they receive timely interventions, coordinated care, and comprehensive support.